Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

NATHBIOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.7%1-day move

₹175.00

prior close

₹167.99

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.0+0.1-0.3-3.7-1.9-2.6-2.3-1.8+0.0-1.7-9.7-4.5-9.1

Up moveDown movePending

AI summary

Nath Bio-Genes submitted its quarterly compliance certificate for Q4 FY26 (ending March 31, 2026) as mandated by SEBI regulation. The certificate, issued by Bigshare Services Pvt. Ltd. (the company's Registrar and Share Transfer Agent), confirms that all securities received for dematerialization during the quarter were properly processed and confirmed to depositories (NSDL/CDSL). The filing further certifies that dematerialization certificates were cancelled after verification, and depository names were updated in the register of members within the required 15-day timeframe. The certificate is signed by CFO Amol Gupta and dated April 15, 2026.

Likely market impact

This is a routine regulatory filing confirming proper handling of shareholder dematerialization requests. No direct impact on stock price or shareholder value — it simply validates compliance with SEBI's operational requirements.